Rare MYT1L disorder shows broad cognitive, behavioral and health needs
A registry study of 20 people found difficulties with thinking and daily skills alongside ADHD symptoms, anxiety, obesity and gastrointestinal problems.
Editorial illustration — not from the study.
Researchers analyzed data from 20 people with MYT1L variants in the Brain Gene Registry, combining genetic information, remote behavioral assessments and electronic health records. Fourteen participants had pathogenic or likely pathogenic variants; the rest had variants whose effects were uncertain.
Those with confirmed MYT1L-related disorder showed marked difficulties in nonverbal cognition and adaptive functioning, especially motor tasks, communication and daily living. Behavioral assessments found frequent ADHD symptoms, conduct problems, oppositional behavior and anxiety, while records also showed recurring developmental delays, speech and language disorders, gastrointestinal problems and obesity. Prescriptions commonly included alpha-2 adrenergic agonists and laxatives.
What the registry showed
The registry data showed significant impairments in nonverbal cognitive ability and adaptive functioning among participants with confirmed MYT1L-related neurodevelopmental disorder, compared with population norms and other neurodevelopmental disorder groups in the registry. Difficulties were particularly evident in motor skills, communication and daily living activities.
Parent-reported behavioral measures showed high levels of ADHD symptoms, conduct problems, oppositional defiance and anxiety. Electronic health records frequently listed developmental delays, speech and language disorders, gastrointestinal problems and obesity. Medication records commonly included alpha-2 adrenergic agonists, such as guanfacine, and laxatives.
The study included 20 people with MYT1L variants, including 14 with pathogenic or likely pathogenic variants and six with variants of uncertain significance. Participants with uncertain variants generally performed better on the remote assessments, but the researchers included them to capture a broader range of features and support future variant interpretation.
Why the profile matters
This study provides a systematic, multi-source description of a rare disorder that has not been extensively characterized through prospective clinical data. The findings indicate that MYT1L-related disorder affects more than cognition: assessments and health records point to needs involving communication, motor abilities, daily living, behavior, gastrointestinal health and weight.
By combining genetic data with standardized remote assessments and clinical records, the Brain Gene Registry can help researchers define the disorder’s natural history and identify areas relevant to clinical management. The results also support attention to both neurodevelopmental and physical health concerns in affected individuals.
Evidence and caveats
The study was an exploratory analysis of registry data from 20 people, using standardized remote questionnaires and assessments alongside electronic health records. It compared participants with MYT1L variants with the broader registry cohort and, where appropriate, with assessment norms.
The sample was small, and six participants had variants of uncertain significance, so not all findings represent confirmed MYT1L-related disorder. Electronic health record information was available only for participants receiving care at certain research centers, and medication data covered only a subset. The study was not designed to establish the disorder’s long-term course or determine whether any medication caused improvement. Larger, longitudinal, age-specific studies are needed.
// Source
American Journal of Medical Genetics Part A · 2026 · DOI: 10.1002/ajmg.a.70321
A study of illicit alcohol in two Ugandan cities found that alcohol strength was inconsistent and sometimes under-declared, reaching 44.2%. Some spirits contained methanol above safe limits, while opaque beers showed bacterial contamination and many production and retail sites had poor sanitation.
Researchers found that bacterial surface-layer proteins can evolve through modular changes and gene transfer, producing different outer structures. In closely related bacteria with the same type of surface layer, only pathogens showed resistance to the antimicrobial molecules LL-37 and lysozyme.
Researchers traced how AlphaFold 3 turns evolutionary differences among related protein sequences into three-dimensional structure predictions. They found that evolutionary diversity matters more than simply adding more sequences, helping explain both the system’s strengths and some of its failures.